On December 31, 2015, FDA released a draft guidance entitled “Public Notification of Emerging Postmarket Medical Device Signals (‘Emerging Signals’),” which stated its plans to take a more aggressive approach to reporting medical device safety warnings to the public.
When the draft guidance was initially published the FDA stated that anyone interested in providing feedback on the document would have until February 29, 2016 to do so. However, “due to the unanticipated high-level of interest from external stakeholders and the medical device community,” the Agency is extending that deadline. On Wednesday, January 27, FDA announced that interested persons will now have until March 29, 2016 to submit any comments, questions, or concerns on the draft guidance.
View our FDA News article for additional information on the contents of the draft guidance.